148 related articles for article (PubMed ID: 2684711)
1. Effects of aging on insulin secretion.
Gumbiner B; Polonsky KS; Beltz WF; Wallace P; Brechtel G; Fink RI
Diabetes; 1989 Dec; 38(12):1549-56. PubMed ID: 2684711
[TBL] [Abstract][Full Text] [Related]
2. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
[TBL] [Abstract][Full Text] [Related]
3. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
[TBL] [Abstract][Full Text] [Related]
4. The metabolic clearance of insulin and the feedback inhibition of insulin secretion are altered with aging.
Fink RI; Revers RR; Kolterman OG; Olefsky JM
Diabetes; 1985 Mar; 34(3):275-80. PubMed ID: 3882495
[TBL] [Abstract][Full Text] [Related]
5. Quantitative study of insulin secretion and clearance in normal and obese subjects.
Polonsky KS; Given BD; Hirsch L; Shapiro ET; Tillil H; Beebe C; Galloway JA; Frank BH; Karrison T; Van Cauter E
J Clin Invest; 1988 Feb; 81(2):435-41. PubMed ID: 3276729
[TBL] [Abstract][Full Text] [Related]
6. Exercise training delineates the importance of B-cell dysfunction to the glucose intolerance of human aging.
Kahn SE; Larson VG; Schwartz RS; Beard JC; Cain KC; Fellingham GW; Stratton JR; Cerqueira MD; Abrass IB
J Clin Endocrinol Metab; 1992 Jun; 74(6):1336-42. PubMed ID: 1592879
[TBL] [Abstract][Full Text] [Related]
7. First-phase insulin secretion has limited impact on postprandial glycemia in subjects with type 2 diabetes: correlations between hyperglycemic glucose clamp and meal test.
Rave K; Sidharta PN; Dingemanse J; Heinemann L; Roggen K
Diabetes Technol Ther; 2010 Feb; 12(2):117-23. PubMed ID: 20105041
[TBL] [Abstract][Full Text] [Related]
8. Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation.
Blackman JD; Polonsky KS; Jaspan JB; Sturis J; Van Cauter E; Thistlethwaite JR
Diabetes; 1992 Oct; 41(10):1346-54. PubMed ID: 1397710
[TBL] [Abstract][Full Text] [Related]
9. Reduction of insulin clearance during hyperglycemic clamp. Dose-response study in normal humans.
Tillil H; Shapiro ET; Rubenstein AH; Galloway JA; Polonsky KS
Diabetes; 1988 Oct; 37(10):1351-7. PubMed ID: 3046967
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance.
Basu R; Breda E; Oberg AL; Powell CC; Dalla Man C; Basu A; Vittone JL; Klee GG; Arora P; Jensen MD; Toffolo G; Cobelli C; Rizza RA
Diabetes; 2003 Jul; 52(7):1738-48. PubMed ID: 12829641
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism.
O'Meara NM; Blackman JD; Sturis J; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):79-84. PubMed ID: 8421108
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects.
Polonsky KS; Given BD; Van Cauter E
J Clin Invest; 1988 Feb; 81(2):442-8. PubMed ID: 3276730
[TBL] [Abstract][Full Text] [Related]
13. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
[TBL] [Abstract][Full Text] [Related]
14. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
Meneilly GS; Elliott T
Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
[TBL] [Abstract][Full Text] [Related]
15. Elevated basal insulin secretion and normal dynamic insulin sensitivity in borderline hypertension.
Piccardo MG; Turchetti G; Rosa MS; Pacini G
Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):244-9. PubMed ID: 10656171
[TBL] [Abstract][Full Text] [Related]
16. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans.
Luzi L; DeFronzo RA
Am J Physiol; 1989 Aug; 257(2 Pt 1):E241-6. PubMed ID: 2669517
[TBL] [Abstract][Full Text] [Related]
17. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
Meneilly GS; Ryan AS; Minaker KL; Elahi D
J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of insulin resistance in aging.
Fink RI; Kolterman OG; Griffin J; Olefsky JM
J Clin Invest; 1983 Jun; 71(6):1523-35. PubMed ID: 6345584
[TBL] [Abstract][Full Text] [Related]
19. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
Mari A
Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
[TBL] [Abstract][Full Text] [Related]
20. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.
Van Cauter E; Mestrez F; Sturis J; Polonsky KS
Diabetes; 1992 Mar; 41(3):368-77. PubMed ID: 1551497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
